CD70 and neoplasm: Preclinical study on NSCLC cell lines and tumor-bearing mice using a combination of anti-CD70 antibody and chemotherapy showed effective NK-cell mediated tumor cell killing and an enhanced intratumoral infiltration of both T and NK cells, as well as an increase in the ratio of CD8 + T cells over Tregs [15].